Integration of observational and causal evidence for the association between adiposity and 17 gastrointestinal outcomes: An umbrella review and meta-analysis
- PMID: 39233338
- DOI: 10.1111/obr.13823
Integration of observational and causal evidence for the association between adiposity and 17 gastrointestinal outcomes: An umbrella review and meta-analysis
Abstract
We systematically reviewed observational and Mendelian randomization (MR) articles that evaluated the association between obesity and 17 gastrointestinal (GI) diseases to integrate causal and observational evidence. A total of 594 observational studies from 26 systematic reviews and meta-analyses and nine MR articles were included. For every 5 kg/m2 increase in body mass index (BMI), there was an increased risk of GI diseases ranging from 2% for rectal cancer (relative risk [RR]: 1.02, 95% confidence interval [CI]: 1.01 to 1.03) to 63% for gallbladder disease (RR: 1.63, 95% CI: 1.50 to 1.77). MR articles indicated that risks of developing GI diseases elevated with each 1 standard deviation increase in genetically predicted BMI, ranging from 11% for Crohn's disease to 189% for nonalcoholic fatty liver disease. Moreover, upper GI conditions were less susceptible, whereas hepatobiliary organs were more vulnerable to increased adiposity. Among the associations between obesity and the 17 GI conditions, causal relationships were inferred from only approximately half (10/17, 59%). This study reveals a substantial gap between observational and causal evidence, indicating that a combined approach is necessary to effectively inform public health policies and guide epidemiological research on obesity and GI diseases.
Keywords: Mendelian randomization; body mass index; gastrointestinal diseases; meta‐analysis; obesity; umbrella review.
© 2024 The Author(s). Obesity Reviews published by John Wiley & Sons Ltd on behalf of World Obesity Federation.
References
REFERENCES
-
- NCD Risk Factor Collaboration (NCD‐RisC). Worldwide trends in body‐mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population‐based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627‐2642. doi:10.1016/S0140‐6736(17)32129‐3
-
- Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378(9793):815‐825. doi:10.1016/s0140‐6736(11)60814‐3
-
- Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life‐years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749‐1768. doi:10.1001/jamaoncol.2019.2996
-
- GBD 2017 Gastro‐oesophageal Reflux Disease Collaborators. The global, regional, and national burden of gastro‐oesophageal reflux disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5(6):561‐581. doi:10.1016/S2468‐1253(19)30408‐X
-
- Ge X, Zheng L, Wang M, Du Y, Jiang J. Prevalence trends in non‐alcoholic fatty liver disease at the global, regional and national levels, 1990‐2017: a population‐based observational study. BMJ Open. 2020;10(8):e036663. doi:10.1136/bmjopen‐2019‐036663
Publication types
MeSH terms
Grants and funding
- 2022R1A2C2009998/National Research Foundation of Korea (NRF)
- HU22C0042/Korea Health Technology R&D Project
- Korea University
- R35-GM124836/National Institute of General Medical Sciences of the NIH
- R01-HL139865/National Heart, Lung, and Blood Institute of the NIH
- R01-HL155915/National Heart, Lung, and Blood Institute of the NIH
- R01HL142711/National Heart Lung and Blood Institute
- R01HL127564/National Heart Lung and Blood Institute
- R01HL148050/National Heart Lung and Blood Institute
- R01HL151283/National Heart Lung and Blood Institute
- R01HL148565/National Heart Lung and Blood Institute
- R01HL135242/National Heart Lung and Blood Institute
- R01HL151152/National Heart Lung and Blood Institute
- R01DK125782/DK/NIDDK NIH HHS/United States
- U01HG011719/HG/NHGRI NIH HHS/United States
- TNE-18CVD04/Fondation Leducq
- Massachusetts General Hospital
- R01DK125782/DK/NIDDK NIH HHS/United States
- U01HG011719/HG/NHGRI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
